红桃视频

Massimiliano Colella is the Chief Executive Officer of CMR, where he leads the company鈥檚 global mission, strategic direction, and long-term development. With an extensive track record across the healthcare ecosystem – including med-tech, hospital systems, and emerging health technologies – he is widely regarded for his ability to transform organisations, accelerate innovation, and deliver sustainable value.

Prior to joining CMR, Massimiliano served as CEO of Evercare Group Ltd, a TPG portfolio Company, overseeing the company鈥檚 operational expansion, strengthening its strategic foundations, and advancing healthcare delivery across diverse regions.

Previously, he served as President of 聽Smith & Nephew, where he led major business units in EMEA, Emerging Markets, Asia Pacific, Canada and LatAm, enhancing competitive positioning, and delivering robust commercial performance across global markets.

Massimiliano鈥檚 executive career began at Johnson & Johnson, where he held a variety of senior leadership roles spanning commercial strategy, business development, and operational management across multiple franchises and divisions.

During his 33-year long career, he and his family 聽have been based in several different countries, including Italy, Czech Republic, UAE, Singapore, Switzerland and the United Kingdom.

In addition to his executive roles, Massimiliano is the Chairman of the Board at Beyeonics Surgical, where he oversees the company鈥檚 strategy and supports its innovations in augmented-reality surgical visualisation systems. He has also served in governance, advisory, and board positions across multiple hospital groups, industry associations聽 and Private Equity firms.

Across all his leadership positions, Massimiliano is recognised for his strategic clarity, people-first leadership, and commitment to advancing global healthcare. He continues to guide CMR with a focus on innovation, operational excellence, and long-term impact.